May 4, 2018 / 8:03 AM / 21 days ago

BRIEF-Sangui Biotech International Q3 Oper Loss Reduced

May 4 (Reuters) - Sangui Biotech International Inc:

* OPERATING LOSS FOR Q3 OF 2018 DECREASED BY USD 6,856 YEAR-ON-YEAR TO USD 68,798.

* 9MTH REVENUES FROM ROYALTY INCOME AND PRODUCT SALES OF USD 65,273 VERSUS USD 47,186 YE AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below